Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison
MORE ABOUT Biocon Ltd
Kiran Mazumdar Shaw
Chairperson
Ravi Mazumdar
Director
Vijay Kumar Kuchroo
Independent Director
M Damodaran
Independent Director
Bobby Parikh
Independent Director
Mayank Verma
Company Sec. & Compli. Officer
SIDDHARTH MITTAL
Managing Director & CEO
Eric Vivek Mazumdar
Director
Naina Lal Kidwai
Independent Director
Peter John Bains
Independent Director
Summary
Biocon Limited is Indias largest and fully-integrated, innovation-led biopharmaceutical company. The Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in the year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind. In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International. Also in the same year, the company had received US funding for proprietary technologies. After a year, in 1990, Biocon had scaled up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level. Biocons R&D and manufacturing facilities received ISO 9001 certification from RWTUV, Germany during the period of 1993. In the year 1994, the company had established the Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector. The commercial success of Biocons proprietary fermentation plant leads to a 3-fold expansion during the year 1996 and also in the same year, the company had leveraged its technology platform to enter biopharmaceuticals and statins. Biocon had spearheads initiatives in human healthcare in the year 1997 through a dedicated manufacturing... Read More
It refers to the market value of the company's publicly traded shares. The market capitalization for Biocon is Rs 35015.50 billion as of 25 Apr, 2024.
Is Biocon a govt company?
Biocon is a non-government public company in India.
What is the promoter shareholding in Biocon?
On 31 December 2023, the promoter shareholding of the company was 60.64%.
Is Biocon profitable?
Biocon Ltd. generated a net profit of Rs 462.70 crore in 2023.
Who is the Managing Director of Biocon Limited?
Siddharth Mittal serves as the managing director of the company.
What is the ROE of Biocon Limited?
The company's ROE is quite fair at 9%. But it still needs to improve.
What is the debt-to-equity ratio of Biocon Limited?
The company's debt-to-equity ratio is 39%, suggesting a positive balance sheet.
What is the stock price CAGR of Biocon Limited?
The company's stock price CAGR is 24% for 10 years, 17% for 5 years, 5% for 3 years, and -21 % for 1 year.
How many times has Biocon Limited given dividends since 2004?
Since 2024, the company has given dividends four times.
Is it a good time to invest in Biocon Limited?
On a trailing 12-month basis, the operating revenue of the company stands at Rs 7290.70 crores. The annual revenue growth of 14% and a 16% pre-tax margin are also great. But the stock is getting mixed reviews.
What is the PB ratio of Biocon?
The PB ratio of Biocon is 1.4.
Which are the key peers to Biocon?
The key peers of Biocon include Aarti Industries Ltd., Glenmark Pharmaceuticals Ltd., Gland Pharma Ltd., Piramal Pharma Ltd., and Syngene International Ltd.
How can I quickly analyze Biocon stock?
You can evaluate the Biocon stock by looking at metrics like the PE ratio, earning per share, price/sales ratio, and price-to-book ratio.
Who's the owner of Biocon?
Kiran Mazumdar Shaw owns Biocon. She is the founder and chairperson of the company.
What is the 52 Week High and Low of Biocon?
It is the highest and lowest price of Biocon over a period of 52 weeks. The 52 week high is Rs 307.10 and the low is Rs 191.55.
What is the PE and PB ratio of Biocon?
The PE ratio is 26.68, and the PB ratio is 1.46.
What is the Share Price of Biocon?
It will keep varying depending on countless factors. The share price of Biocon is Rs 0.00 as of 13 Feb 2024.
How to Buy Biocon Share?
Create your demat account on IIFL with proper KYC documents and undergo verification to buy the stock.